KIDRON NADAV Insider Trading Activity

Average Profitability
24.37%
Insider Buys Quantity
7
Insider Buys Sum
$297,537.36
Insider Sells Quantity
2
Insider Sells Sum
$4.42M

Insider Activity of KIDRON NADAV

Biography of KIDRON NADAV

No biography is available at this moment.

2023-03-16PurchaseOramed Pharmaceuticals Inc.
ORMP
President and CEO
26,000
0.0615%
$2.04$53,014+24.27%
2023-03-14PurchaseOramed Pharmaceuticals Inc.
ORMP
President and CEO
100,000
0.2466%
$2.01$201,000+29.74%
2021-08-09SaleOramed Pharmaceuticals Inc.
ORMP
President and CEO
220,000
0.7367%
$20.11$4.42M-50.46%
2018-07-11PurchaseOramed Pharmaceuticals Inc.
ORMP
President and CEO
244
0.0014%
$5.92$1,444-36.76%
2018-07-10SaleOramed Pharmaceuticals Inc.
ORMP
President and CEO
122
0.0007%
$5.98$730-36.67%
2016-05-12PurchaseOramed Pharmaceuticals Inc.
ORMP
President and CEO
2,000
0.0157%
$6.98$13,963+1.58%
2015-05-12PurchaseOramed Pharmaceuticals Inc.
ORMP
President and CEO
1,200
0.0113%
$6.62$7,942+4.62%
2015-03-19PurchaseOramed Pharmaceuticals Inc.
ORMP
President and CEO
3,200
0.0292%
$3.93$12,584+67.92%
2015-03-18PurchaseOramed Pharmaceuticals Inc.
ORMP
President and CEO
2,000
0.0188%
$3.79$7,590+79.02%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.